Haplotypes in CCR5-CCR2, CCL3 and CCL5 are associated with natural resistance to HIV-1 infection in a Colombian cohort
Abstract
Introduction: Variants in genes encoding for HIV-1 co-receptors and their natural ligands have been individually associated to natural resistance to HIV-1 infection. However, the simultaneous presence of these variants has been poorly studied.
Objective: To evaluate the association of single and multilocus haplotypes in genes coding for the viral co-receptors CCR5 and CCR2, and their ligands CCL3 and CCL5, with resistance or susceptibility to HIV-1 infection.
Materials and methods: Nine variants in CCR5-CCR2, two SNPs in CCL3 and two in CCL5 were genotyped by PCR-RFLP in 35 seropositive (cases) and 49 HIV-1-exposed seronegative Colombian individuals (controls). Haplotypes were inferred using the Arlequin software, and their frequency in individual or combined loci was compared between cases and controls by the chi-square test. A p’ value <0.05 after Bonferroni correction was considered significant.
Results: Homozygosis of the human haplogroup (HH) E was absent in controls and frequent in cases, showing a tendency to susceptibility. The haplotypes C-C and T-T in CCL3 were associated with susceptibility (p’=0.016) and resistance (p’<0.0001) to HIV-1 infection, respectively. Finally, in multilocus analysis, the haplotype combinations formed by HHC in CCR5-CCR2, T-T in CCL3 and G-C in CCL5 were associated with resistance (p’=0.006).
Conclusion: Our results suggest that specific combinations of variants in genes from the same signaling pathway can define an HIV-1 resistant phenotype. Despite our small sample size, our statistically significant associations suggest strong effects; however, these results should be further validated in larger cohorts.
Downloads
References
Frade JM, Llorente M, Mellado M, Alcamí J, Gutiérrez-Ramos JC, Zaballos A, et al. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J Clin Invest. 1997;100:497-502. http://dx.doi.org/10.1172/JCI119558
González E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA. 1999;96:12004-9. http://dx.doi.org/10.1073/pnas.96.21.12004
González E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1 alpha: Impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A. 2001;98:5199-204. http://dx.doi.org/10.1073/pnas.091056898
Ometto L, Zanchetta M, Mainardi M, De Salvo GL, García-Rodríguez MC, Gray L, et al. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS. 2000;14:1721-9.
Zapata W, Aguilar-Jiménez W, Pineda-Trujillo N, Rojas W, Estrada H, Rugeles MT. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia. AIDS Res Hum Retroviruses. 2013;29:1594-603. http://dx.doi.org/10.1089/aid.2012.0299
Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, et al. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis.2003;188:1461-72. http://dx.doi.org/10.1086/379038
Nguyen L, Li M, Chaowanachan T, Hu DJ, Vanichseni S, Mock PA, et al. CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. AIDS. 2004;18:1327-33. http://dx.doi.org/10.1097/01.aids.0000131303.39957.15
Li M, Song R, Masciotra S, Soriano V, Spira TJ, Lal RB, et al. Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression. AIDS Res Hum Retroviruses. 2005;21:111-5. http://dx.doi.org/10.1089/aid.2005.21.111
Rugeles MT, Solano F, Díaz FJ, Bedoya VI, Patiño PJ. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV). J Clin Virol. 2002;23:161-9. http://dx.doi.org/10.1016/S1386-6532(01)00219-0
Rousset F. Genepop’007: A complete reimplementation of the Genepop software for Windows and Linux. Mol Ecol Resour. 2008;8:103-6. http://dx.doi.org/10.1111/j.1471-8286.2007.01931.x
Excoffier L, Lischer H. Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010;10:564-7. http://dx.doi.org/10.1111/j.1755-0998.2010.02847.x
Librado P, Rozas J. DnaSP v5: A software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25:1451-2. http://dx.doi.org/10.1093/bioinformatics/btp187
Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet. 2005;14:1691-8. http://dx.doi.org/10.1093/hmg/ddi177
Bedoya G, Montoya P, García J, Soto I, Bourgeois S, Carvajal L, et al. Admixture dynamics in Hispanics: A shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci USA. 2006;103:7234-9. http://dx.doi.org/10.1073/pnas.0508716103
Rojas W, Parra MV, Campo O, Caro MA, Lopera JG, Arias W, et al. Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers. Am J Phys Anthropol. 2010;143:13-20. http://dx.doi.org/10.1002/ajpa.21270
Jiang D, Mummidi S, Ahuja SK, Jarrett HW. CCR5 promoter haplotype transcription complex characterization. J Health Care Poor Underserved. 2011;22(Suppl.):73-90.
http://dx.doi.org/10.1353/hpu.2011.0169
Mummidi S, Bamshad M, Ahuja SS, González E, Feuillet PM, Begum K, et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides. J Biol Chem. 2000;275:18946-61. http://dx.doi.org/10.1074/jbc.M000169200
Liu H, Nakayama EE, Theodorou I, Nagai Y, Likanonsakul S, Wasi C, et al. Polymorphisms in CCR5 chemokine receptor gene in Japan. Int J Immunogenet. 2007;34:325-35. http://dx.doi.org/10.1111/j.1744-313X.2007.00694.x
Tang J, Shelton B, Makhatadze NJ, Zhang Y, Schaen M, Louie LG, et al. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J Virol. 2002;76:662-72. http://dx.doi.org/10.1128/JVI.76.2.662-672.2002
Kawamura T, Gulden FO, Sugaya M, McNamara DT, Borris DL, Lederman MM, et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci USA. 2003;100:8401-6. http://dx.doi.org/10.1073/pnas.1432450100
Gong Z, Tang J, Xiang T, Zhang L, Liao Q, Liu W, et al. Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and susceptibility to HIV-1 infection: A metaanalysis. PLoS One. 2013;8:e60683. http://dx.doi.org/10.1371/journal.pone.0060683
He J, Li X, Tang J, Jin T, Liao Q, Hu G. Association between chemotactic chemokine ligand 5 -403G/A polymorphism and risk of human immunodeficiency virus-1 infection: A metaanalysis. Onco Targets Ther. 2015;8:727-34. http://dx.doi.org/10.2147/OTT.S78581
Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol. 2012;30:1095-106. http://dx.doi.org/10.1038/nbt.2422
Some similar items:
- Ana María Mejía-Jaramillo, Geysson Javier Fernández, Marleny Montilla, Rubén Santiago Nicholls, Omar Triana-Chávez, Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia , Biomedica: Vol. 32 No. 2 (2012)
- Juan J. Yunis, Luis E. Acevedo, David S. Campo, Emilio J. Yunis, Geno-geographic origin of Y-specific STR haplotypes in a sample of Caucasian-Mestizo and African-descent male individuals from Colombia , Biomedica: Vol. 33 No. 3 (2013)
- Ana Luz Galván-Díaz, Juan Carlos Alzate, Esteban Villegas, Sofía Giraldo, Jorge Botero, Gisela García, Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy , Biomedica: Vol. 41 No. Supl. 1 (2021): Mayo, Parasitología médica
- Leslie Alejandra Ramírez, Elsy Arlene Pérez-Padilla, Francisco García-Oscos, Humberto Salgado, Marco Atzori, Juan Carlos Pineda, A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis , Biomedica: Vol. 38 No. 3 (2018)
- María Atencia, Angie Toro-Cantillo, Richard Hoyos-López, Genetic diversity and population structure of Anopheles triannulatus s. l. in the department of Córdoba, Colombia, using DNA barcoding , Biomedica: Vol. 38 No. Sup. 2 (2018): Suplemento 2, Medicina tropical
- José Moreno-Montoya, Ana M. Barragán, Margin Martínez, Amanda Rodríguez, Ángela Carmela González, Quality of life and perceived social support in people with HIV in Bogotá, Colombia , Biomedica: Vol. 38 No. 4 (2018)
- Mauricio Beltrán, María Cristina Navas, María Patricia Arbeláez, Jorge Donado, Sergio Jaramillo, Fernando De la Hoz, Cecilia Estrada, Lucía del Pilar Cortés, Amalia de Maldonado, Gloria Rey, Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia , Biomedica: Vol. 29 No. 2 (2009)
- Yazmin Rocío Arias, Karime Osorio-Arango, Brayan Bayona, Guadalupe Ercilla, Mauricio Beltrán-Durán, Determination of HLA-A, -B and -DRB1 polymorphism in brain dead organ donors representative of the Colombian general population, 2007-2014 , Biomedica: Vol. 37 No. 2 (2017)
- Wbeimar Aguilar-Jiménez, Wildeman Zapata, María Teresa Rugeles, Differential expression of human beta defensins in placenta and detection of allelic variants in the DEFB1 gene from HIV-1 positive mothers , Biomedica: Vol. 31 No. 1 (2011)
- María Patricia Arbeláez, Alexánder Arbeláez, Rubén Darío Gómez, Carlos Rojas, Lázaro Vélez, Sonia Luz Arias, Jorge Nagles, Luz Marina Peláez, Gloria Betancourt, Gloria Velásquez, Effectiveness of prophylaxis against tuberculosis in patients infected with HIV , Biomedica: Vol. 27 No. 4 (2007)

Altmetric

- Citations
- Citation Indexes: 11
- Usage
- Full Text Views: 525
- Abstract Views: 105
- Captures
- Readers: 20
Article metrics | |
---|---|
Abstract views | 244 |
Galley vies | 246 |
PDF Views | 240 |
HTML views | 6 |
Other views | 0 |